285 related articles for article (PubMed ID: 15009866)
1. Effects of pretreatment with intravenous flecainide on efficacy of external cardioversion of persistent atrial fibrillation.
Climent VE; Marin F; Mainar L; Gomez-Aldaravi R; Martinez JG; Chorro FJ; Roman P; Sogorb F
Pacing Clin Electrophysiol; 2004 Mar; 27(3):368-72. PubMed ID: 15009866
[TBL] [Abstract][Full Text] [Related]
2. Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation.
Boriani G; Biffi M; Capucci A; Bronzetti G; Ayers GM; Zannoli R; Branzi A; Magnani B
J Am Coll Cardiol; 1999 Feb; 33(2):333-41. PubMed ID: 9973012
[TBL] [Abstract][Full Text] [Related]
3. Predictors of sinus rhythm after electrical cardioversion of atrial fibrillation: results from a data mining project on the Flec-SL trial data set.
Oto E; Okutucu S; Katircioglu-Öztürk D; Güvenir HA; Karaagaoglu E; Borggrefe M; Breithardt G; Goette A; Ravens U; Steinbeck G; Wegscheider K; Oto A; Kirchhof P
Europace; 2017 Jun; 19(6):921-928. PubMed ID: 27377074
[TBL] [Abstract][Full Text] [Related]
4. Randomised double blind trial of oral versus intravenous flecainide for the cardioversion of acute atrial fibrillation.
Alp NJ; Bell JA; Shahi M
Heart; 2000 Jul; 84(1):37-40. PubMed ID: 10862585
[TBL] [Abstract][Full Text] [Related]
5. Does flecainide regain its antiarrhythmic activity after electrical cardioversion of persistent atrial fibrillation?
Tieleman RG; Van Gelder IC; Bosker HA; Kingma T; Wilde AA; Kirchhof CJ; Bennekers JH; Bracke FA; Veeger NJ; Haaksma J; Allessie MA; Crijns HJ
Heart Rhythm; 2005 Mar; 2(3):223-30. PubMed ID: 15851308
[TBL] [Abstract][Full Text] [Related]
6. Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial.
Kirchhof P; Fetsch T; Hanrath P; Meinertz T; Steinbeck G; Lehmacher W; Breithardt G
Am Heart J; 2005 Nov; 150(5):899. PubMed ID: 16290956
[TBL] [Abstract][Full Text] [Related]
7. [Effects of pretreatment with amiodarone infusion in patients with persistent atrial fibrillation submitted to external electrical cardioversion: a single center experience].
Maffè S; Paffoni P; Perucca A; Dellavesa P; Parravicini U; Nicali R; Bielli M; Paino AM; Signorotti F; Franchetti Pardo N; Zenone F; Zanetta M
G Ital Cardiol (Rome); 2008 Jul; 9(7):504-8. PubMed ID: 18678217
[TBL] [Abstract][Full Text] [Related]
8. Flecainide for cardioversion in patients at elevated cardiovascular risk and persistent atrial fibrillation: a prospective observational study.
Er F; Aslan O; Caglayan E; Gassanov N; Nia AM; Erdmann E; Rosenkranz S
Clin Res Cardiol; 2010 Jun; 99(6):369-73. PubMed ID: 20180126
[TBL] [Abstract][Full Text] [Related]
9. Treatment of recent onset atrial fibrillation with intravenous sotalol and/or flecainide.
Peters FP; Braat SH; Heymeriks J; Wellens HJ
Neth J Med; 1998 Sep; 53(3):93-6. PubMed ID: 9803139
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological cardioversion of atrial fibrillation: current management and treatment options.
Boriani G; Diemberger I; Biffi M; Martignani C; Branzi A
Drugs; 2004; 64(24):2741-62. PubMed ID: 15563247
[TBL] [Abstract][Full Text] [Related]
11. Tissue velocity imaging of the left atrium predicts response to flecainide in patients with acute atrial fibrillation.
Limantoro I; De Vos CB; Delhaas T; Marcos E; Blaauw Y; Weijs B; Tieleman RG; Pisters R; Schotten U; Van Gelder IC; Crijns HJ
Heart Rhythm; 2014 Mar; 11(3):478-84. PubMed ID: 24321238
[TBL] [Abstract][Full Text] [Related]
12. Intravenous vernakalant in comparison with intravenous flecainide in the cardioversion of recent-onset atrial fibrillation.
Pohjantähti-Maaroos H; Hyppölä H; Lekkala M; Sinisalo E; Heikkola A; Hartikainen J
Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):114-120. PubMed ID: 28849946
[TBL] [Abstract][Full Text] [Related]
13. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment.
Oral H; Souza JJ; Michaud GF; Knight BP; Goyal R; Strickberger SA; Morady F
N Engl J Med; 1999 Jun; 340(24):1849-54. PubMed ID: 10369847
[TBL] [Abstract][Full Text] [Related]
14. Incidence and management of early recurrent atrial fibrillation (ERAF) after transthoracic electrical cardioversion.
Siaplaouras S; Jung J; Buob A; Heisel A
Europace; 2004 Jan; 6(1):15-20. PubMed ID: 14697721
[TBL] [Abstract][Full Text] [Related]
15. Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation.
Reisinger J; Gatterer E; Heinze G; Wiesinger K; Zeindlhofer E; Gattermeier M; Poelzl G; Kratzer H; Ebner A; Hohenwallner W; Lenz K; Slany J; Kuhn P
Am J Cardiol; 1998 Jun; 81(12):1450-4. PubMed ID: 9645896
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of pad placement for electrical cardioversion of atrial fibrillation/flutter: a systematic review.
Kirkland S; Stiell I; AlShawabkeh T; Campbell S; Dickinson G; Rowe BH
Acad Emerg Med; 2014 Jul; 21(7):717-26. PubMed ID: 25117151
[TBL] [Abstract][Full Text] [Related]
17. Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: a placebo-controlled, multicenter study.
Okishige K; Nishizaki M; Azegami K; Igawa M; Yamawaki N; Aonuma K;
Am Heart J; 2000 Sep; 140(3):e13. PubMed ID: 10966544
[TBL] [Abstract][Full Text] [Related]
18. Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial.
Kirchhof P; Andresen D; Bosch R; Borggrefe M; Meinertz T; Parade U; Ravens U; Samol A; Steinbeck G; Treszl A; Wegscheider K; Breithardt G
Lancet; 2012 Jul; 380(9838):238-46. PubMed ID: 22713626
[TBL] [Abstract][Full Text] [Related]
19. [Idiopathic atrial fibrillation of recent onset and atrial stunning: the echocardiographic evidence after pharmacological cardioversion].
Ciolli A; De Sisti A; Montenero AS; Sanna T; Lo Sardo G; Palamara A
Cardiologia; 1998 Oct; 43(10):1077-82. PubMed ID: 9922572
[TBL] [Abstract][Full Text] [Related]
20. VErapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study).
De Simone A; De Pasquale M; De Matteis C; Canciello M; Manzo M; Sabino L; Alfano F; Di Mauro M; Campana A; De Fabrizio G; Vitale DF; Turco P; Stabile G
Eur Heart J; 2003 Aug; 24(15):1425-9. PubMed ID: 12909071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]